1·To be the best calcium sulfate supplier of China !
做中国最好的硫酸钙（石膏）供应商！
2·Discussed the calcium sulfate whisker HIPS enhance the mechanism.
讨论了硫酸钙晶须增强HIPS的机理。
3·EDTMPS shows better antiscale effects to calcium sulfate and barium sulfate.
EDTMPS对硫酸钙、硫酸钡垢的阻垢效果好。
4·The effect of ultrasonic wave on calcium sulfate crystallization is studied.
研究了超声对硫酸钙结晶过程的影响。
5·The mixture includes from about 50% to about 98% by weight calcium sulfate hemihydrate.
所述混合物包括约50重量%至约98%的半水合硫酸钙。
6·The yellow substance was gypsum, or calcium sulfate dehydrate, a common component of plaster.
这种黄色的物质叫做脱水硫化钙，通常是石膏的一种组成部分。
7·The results analyzed by X-ray show that the content of anhydrous calcium sulfate is 97.0% by weight.
射线衍射分析表明，产品中无水硫酸钙相的含量为97.0%。
8·Based on the property of the model drug, we selected Calcium Sulfate as dilute, Hydrogenated Castor Oil as binder.
针对模型药物的性质，选择了硫酸钙为稀释剂，氢化蓖麻油为粘合剂。
9·This study used as a modifier of calcium sulfate, NBS for toughener, HIPS as the theme of plastic polymer composites.
本研究采用以硫酸钙为改性剂，NBS为增韧剂，HIPS为主题塑料组成高分子复合材料。
10·Under calcium sulfate higher than the saturation or high concentration of calcium ions, it has high scale dispersion.
在硫酸钙盐高过饱和度或高钙离子浓度下，具有高效阻垢分散性。
1·AIM: To investigate the osteogenetic ability of calcium sulfate bone graft in posterolateral lumbar spinal fusion by comparing with local compression bone.
目的：在腰椎后外侧融合中，通过与自体减压骨进行比较，评价医用硫酸钙在腰椎后外侧融合中的成骨能力。
2·The effect of ultrasonic wave on calcium sulfate crystallization is studied.
研究了超声对硫酸钙结晶过程的影响。
3·The results show that: calcium sulfate whisker HIPS modified its mechanical properties have a certain effect of the increase, melt flow increased, but the heat resistance has declined.
研究结果表明：硫酸钙晶须改性HIPS对其力学性能有一定的增强效果，熔体流动性增加，但对耐热性有所下降。
4·The results show that with the atomic number of I cluster elements increasing from the top down, they are easier to form complex salts with calcium sulfate, however, the rules is not obvious.
结果表明，I簇元素从上到下随原子序数增加，与硫酸钙形成复盐的难度逐渐降低，但规律性不明显。
5·Based on the property of the model drug, we selected Calcium Sulfate as dilute, Hydrogenated Castor Oil as binder.
针对模型药物的性质，选择了硫酸钙为稀释剂，氢化蓖麻油为粘合剂。